Concord Biotech Q4 Results
- BSE: 543960
- NSE: CONCORDBIO
- ISIN: INE338H01029
- Sector: -
BSE
2,004
-13.05 (-0.65%)
-13.05 (-0.65%)Volume3.40 K
Updated: Fri 18 Oct, 2024 | 15:29:51
NSE
2,018.05-0.85 (-0.04%)
-0.85 (-0.04%)Volume78.65 K
Updated: Fri 18 Oct, 2024 | 15:45:41
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Note: Comparison is on QoQ basis
Quarterly - Concord Biotech Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 24 | Dec 23 | QoQ Comp | Mar 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 318.97 | 240.80 | -% | 853.17 | -% |
| Selling/ General/ Admin Expenses Total | 33.96 | 30.67 | -% | 110.28 | -% |
| Depreciation/ Amortization | 13.72 | 13.54 | -% | 54.03 | -% |
| Other Operating Expenses Total | 61.88 | 57.11 | -% | 219.39 | -% |
| Total Operating Expense | 198.40 | 148.40 | -% | 563.91 | -% |
| Operating Income | 120.57 | 92.39 | -% | 289.26 | -% |
| Net Income Before Taxes | 128.72 | 103.10 | -% | 322.01 | -% |
| Net Income | 95.02 | 77.57 | -% | 240.09 | -% |
| Diluted Normalized EPS | 9.08 | 7.41 | -% | 22.95 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01Hyundai IPO allotment status finalised: Latest GMP, how to check application status online, find direct links here
2 min read12:07 PM IST - Markets
02Hyundai IPO GMP crashes ahead of listing in the coming week. What does it mean?
2 min read03:52 PM IST - Markets
03Muhurat trading 2024 date on October 31 or November 1: Date, time, other details
2 min read05:50 PM IST